Please login to the form below

Not currently logged in
Email:
Password:

Orphacol

This page shows the latest Orphacol news and features for those working in and with pharma, biotech and healthcare.

EC sets up expert group on rare diseases

EC sets up expert group on rare diseases

approve a previously-rejected drug - CTRS' Orphacol - earlier this month.

Latest news

  • Court orders EC to approve rejected orphan medicine Court orders EC to approve rejected orphan medicine

    Says CTRS should be allowed to market Orphacol for the treatment of rare bile condition. ... The battle pitched small French pharma company Cell Therapies Research &Services (CTRS) against the Commission and focused on Orphacol (cholic acid), a drug

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics